THE EFFICACY OF FESOTERODINE FOR THE TREATMENT OF NEUROGENIC DETRUSOR OVERACTIVITY AND/OR LOW COMPLIANCE BLADDER.

被引：0
|
作者：
Kaga, K. [1 ]
Yamanishi, T. [1 ]
Fuse, M. [2 ]
Kaga, M. [2 ]
Shibata, C. [1 ]
Uchiyama, T. [1 ]
Ichikawa, T. [2 ]
机构：
[1] Dokkyo Med Univ, Continence Ctr, Dept Urol, Mibu, Tochigi, Japan
[2] Chiba Univ, Grad Sch Med, Dept Urol, Chiba, Japan
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
201
引用
收藏
页码：S183 / S185
页数：3
相关论文
共 50 条
  • [41] Early Fesoterodine Fumarate Administration Prevents Neurogenic Detrusor Overactivity in a Spinal Cord Transected Rat Model
    Biardeau, Xavier
    Przydacz, Mikolaj
    Aharony, Shachar
    Loutochin, George
    Campeau, Lysanne
    Kyheng, Maeva
    Corcos, Jacques
    PLOS ONE, 2017, 12 (01):
  • [42] Efficacy of botulinum-A toxin bladder injections for the treatment of neurogenic detrusor overactivity in multiple sclerosis patients:: An objective and subjective analysis
    Schulte-Baukloh, H
    Schobert, J
    Stolze, T
    Stürzebecher, B
    Weiss, C
    Knispel, HH
    NEUROUROLOGY AND URODYNAMICS, 2006, 25 (02) : 110 - 115
  • [43] Treatment of Bladder Diverticula, Impaired Detrusor Contractility, and Low Bladder Compliance
    Powell, Charles R.
    Kreder, Karl
    UROLOGIC CLINICS OF NORTH AMERICA, 2009, 36 (04) : 511 - +
  • [44] Efficacy of fesoterodine fumarate in Neurogenic Detrusor Overactivity (NDO) due to Spinal Cord Lesion (SCL) or Multiple Sclerosis (MS) - A prospective study
    Konstantinidis, C.
    Samarinas, M.
    Tzitzika, M.
    Thomas, C.
    Kratiras, Z.
    Giannitsas, K.
    Athanasopoulos, A.
    EUROPEAN UROLOGY, 2021, 79 : S25 - S26
  • [45] Botulinum A toxin injections into the detrusor: An effective treatment in idiopathic and neurogenic detrusor overactivity?
    Kessler, TM
    Danuser, H
    Schumacher, M
    Studer, UE
    Burkhard, FC
    NEUROUROLOGY AND URODYNAMICS, 2005, 24 (03) : 231 - 236
  • [46] Botulinum A toxin injections into the detrusor: An effective treatment in idiopathic and neurogenic detrusor overactivity?
    Kessler, TM
    Danuser, H
    Schumacher, M
    Studer, UE
    Burkhard, FC
    JOURNAL OF UROLOGY, 2005, 173 (04): : 304 - 305
  • [47] ONABOTULINUMTOXINA VERSUS INCOBOTULINUMTOXINA IN THE TREATMENT OF IDIOPATHIC AND NEUROGENIC DETRUSOR OVERACTIVITY
    Gubbiotti, M.
    Rubilotta, E.
    Balzarro, M.
    Bini, V
    Giannantoni, A.
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S200 - S201
  • [48] Botulinum A toxin for neurogenic detrusor overactivity: sustained efficacy with repeated dosing
    Nature Clinical Practice Urology, 2005, 2 (6): : 267 - 267
  • [49] Low but sustained detrusor contractility, detrusor retrospective analysis of treatment outcomes and overactivity and bladder outlet obstruction in female medical care of patients with neurogenic detrusor patients with multiple sclerosis
    Tubaro, A.
    Arrighi, M.
    De Nunzio, C.
    Trucchi, A.
    Miano, L.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 212 - 212
  • [50] THE EFFICACY OF ONABOTULINUMTOXIN A IN PATIENTS WITH PARKINSON'S DISEASE AND NEUROGENIC DETRUSOR OVERACTIVITY
    Arianayagam, Ranjan
    Chan, Lewis
    Gani, Johan
    O'Connell, Helen
    Tse, Vincent
    Yao, Henry
    JOURNAL OF UROLOGY, 2019, 201 (04): : E94 - E95
12345